Two Sigma Advisers
AGN

Two Sigma Advisers’s Allergan plc AGN Stock Holding History

Two Sigma Advisers’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-1,000
Closed -$223K – 2783
2014
Q2 		$223K Buy
+1,000
New +$207K ﹤0.01% 2217
2014
Q1 		– Sell
-7,000
Closed -$1.18M – 2633
2013
Q4 		$1.18M Sell
7,000
-2,000
-22% -$313K 0.01% 1053
2013
Q3 		$1.3M Buy
9,000
+7,100
+374% +$946K 0.02% 832
2013
Q2 		$240K Buy
+1,900
New +$215K ﹤0.01% 1865

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Two Sigma Advisers's AGN Position: Q2 2020 in Review

Two Sigma Advisers sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 511,100 shares — an estimated $90.5M sold.

Two Sigma Advisers first reported a position in AGN in Q2 2013 and held it in 14 quarters. The position peaked at $188M in Q1 2016. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Two Sigma Advisers reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Two Sigma Advisers sold 511,100 Allergan plc shares in Q2 2020, an estimated $90.5M.
  • Two Sigma Advisers first reported a position in Allergan plc in Q2 2013 and held it in 14 quarters.
  • Two Sigma Advisers's Allergan plc position peaked at $188M in Q1 2016.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Two Sigma Advisers's 13F filing for Q2 2020, filed 14 Aug 2020.